Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zilan Zhong
Institution:
Guangzhou University of Chinese Medicine
Observed institution:
Guangzhou University of Chinese Medicine
ORCID:
0009-0000-3750-3005
Observed ORCID:
0009-0000-3750-3005
OpenAlex ID:
A5109750316
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
2024
·
Bohui Zheng
, Manting Liu
, et al.
·
Medicine
·
19
Epidemiological and demographic analysis of liver cancer attributable to modifiable risk factors from 1990 to 2021
2025
·
Yingwu Zhao
, Xue Peng
, et al.
·
Scientific Reports
·
11
PDF
A systematic analysis and prediction of the disease burden of ischemic heart disease caused by hyperglycemia
2025
·
Jianxing Chen
, Wenlinng Zeng
, et al.
·
Journal of Diabetes Investigation
·
4
Gut Microbiota‐Non‐Coding RNA Axis in Immune Modulation and Disease: From Mechanisms to Clinical Translation
2026
·
Bonan Chen
, Guoming Chen
, et al.
·
Advanced Science
·
2
Hotspots in Traditional Chinese Medicine for osteoporotic fracture treatment from 2014 to 2024: A bibliometric analysis
2025
·
Zilan Zhong
, Jiarui Lin
, et al.
·
European Journal of Integrative Medicine
·
2
Drug-induced pulmonary edema: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS)
2025
·
Zilan Zhong
, Manting Liu
, et al.
·
Brazilian Journal of Medical and Biological Research
·
2
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
2025
·
DongQiang Luo
, Jiyuan Zheng
, et al.
·
Expert Opinion on Drug Safety
·
1
From cancer safety signals to cardio-oncology translation: a dual-database bibliometric and BERTopic semantic analysis of SGLT2 inhibitor research in oncology (2014–2026)
2026
·
Xianqin Tang
, Wenlong Niu
, et al.
·
Frontiers in Oncology
PDF
Charting the Therapeutic Landscape of Naringin in Osteopathic and Metabolic Medicine
2026
·
Zilan Zhong
, Pingjin Xie
, et al.
·
Endocrine Metabolic & Immune Disorders - Drug Targets
Targeting the redox and mitochondrial barrier with a naringin-releasing bioactive composite film patch for osteoporotic bone defect repair
2026
·
Jizhi Ma
, Dongwei Sun
, et al.
·
Phytomedicine
Show more works
View as search
Works count:
10
Citation count:
41
H-index:
3
I10-index:
2
Year
Topic
Type